{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:50:18Z","timestamp":1785941418139,"version":"3.56.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000683","name":"Royal Society of Tropical Medicine & Hygiene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR23202"],"award-info":[{"award-number":["NIHR23202"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The study evaluated COVID-19 vaccine uptake and the barriers and facilitators influencing COVID-19 vaccine uptake among key populations living with HIV\/AIDS in Rivers State, Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A key population-based cross-sectional study employed purposive sampling to recruit 458 participants from one-stop shops between April\u2013June 2024. Data collection tools were integrated into a Kobo database. SPSS version 27 (IBM, Armonk, USA) for descriptive and inferential statistics (Chi-square and bivariate logistic regression) analysed vaccine uptake and associated factors, with significance determined at p&amp;lt;0.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The COVID-19 vaccine uptake was 54.1%, with 22.3% partially vaccinated and 31.8% fully vaccinated. Pfizer-BioNTech (43.5%) and Moderna (22.2%) were the most administered vaccines. Key barriers included lack of information (91.7%), vaccine side effects concerns (88.0%), and distrust in vaccine safety (95.2%). Younger participants, those with shorter antiretroviral therapy (ART) durations, single individuals, and unemployed participants showed significantly lower vaccine uptake (\u03c7\u00b2=48.266, 37.689, 29.131, and 62.136; p&amp;lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Moderate vaccine uptake highlights gaps in COVID-19 vaccination among key populations. To improve vaccine uptake, tailored interventions addressing stigma, misinformation, and access barriers are recommended. Leveraging community leaders and integrating vaccines into HIV\/AIDS care programs can enhance acceptance and delivery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/trstmh\/trag005","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:22:35Z","timestamp":1768220555000},"page":"522-532","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 vaccine uptake, barriers and facilitators among key populations living with HIV\/AIDS in Rivers State, Nigeria: a cross-sectional quantitative study"],"prefix":"10.1093","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7244-3199","authenticated-orcid":false,"given":"Uebari","family":"Korfii","sequence":"first","affiliation":[{"name":"Research Coordination Unit, Study Plus Hub LTD , Port Harcourt 500261 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golden","family":"Owhonda","sequence":"additional","affiliation":[{"name":"Rivers State Ministry of Health Department of Public Health and Disease Control, , Port Harcourt 500101 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogers Bariture","family":"Kanee","sequence":"additional","affiliation":[{"name":"University of Port Harcourt African Centre of Excellence for Public Health and Toxicological Research, , Port Harcourt 500272 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihuoma Aaron","family":"Wali","sequence":"additional","affiliation":[{"name":"Rivers State University Department of Community Medicine, , Port Harcourt 500101 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viome Amakuro","family":"Showers","sequence":"additional","affiliation":[{"name":"University of the Western Cape Department of Statistics and Population Studies, , Cape Town 7535 ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Aigbogun Jr","sequence":"additional","affiliation":[{"name":"Solina Centre for International Development and Research (SCIDaR) , Abuja 900299 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mueka Edna","family":"Neenwi","sequence":"additional","affiliation":[{"name":"Rivers State University Department of Haematology and Blood Transfusion Science, , Port Harcourt 500101 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Akpona","sequence":"additional","affiliation":[{"name":"Centre for Population Health Initiatives Program Unit, , Port Harcourt 500272 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngozi","family":"Ajaero","sequence":"additional","affiliation":[{"name":"Institute of Human Virology Prevention, Care and Treatment Unit, , Nigeria, Abuja 900108 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adedamola","family":"Ade-Dosumu","sequence":"additional","affiliation":[{"name":"Program Unit, Diadem Consults , Port Harcourt 500101 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fauwzia","family":"Sanusi","sequence":"additional","affiliation":[{"name":"Solina Centre for International Development and Research (SCIDaR) , Abuja 900299 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damilola","family":"Bashorun","sequence":"additional","affiliation":[{"name":"Solina Centre for International Development and Research (SCIDaR) , Abuja 900299 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etukokwu Ijeoma","family":"Uchechukwu","sequence":"additional","affiliation":[{"name":"Program Unit, Evolving Women Foundation , Port Harcourt 500101 ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"issue":"6","key":"2026050406265061300_bib1","first-page":"1073","article-title":"The impact of COVID-19 on health and health systems","volume":"31","author":"Haileamlak","year":"2021","journal-title":"Ethiop J Health Sci"},{"issue":"3","key":"2026050406265061300_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Micro"},{"issue":"6","key":"2026050406265061300_bib3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-011879","article-title":"Factors, enablers and challenges for COVID-19 vaccine development","volume":"8","author":"Excler","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"10278","key":"2026050406265061300_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","article-title":"Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment","volume":"397","author":"Wouters","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"2026050406265061300_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat Med"},{"issue":"10","key":"2026050406265061300_bib6","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/covid3100103","article-title":"Effectiveness of COVID-19 vaccination on transmission: a systematic review","volume":"3","author":"Oordt-Speets","year":"2023","journal-title":"COVID"},{"issue":"4","key":"2026050406265061300_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2185\/jrm.2023-008","article-title":"Uptake and impact of COVID-19 vaccination among HIV key populations: a cohort study from Tamil Nadu, India","volume":"18","author":"Saleem","year":"2023","journal-title":"J Rural Med"},{"issue":"2","key":"2026050406265061300_bib8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2196\/25623","article-title":"Key population hotspots in Nigeria for targeted HIV program planning: mapping, validation, and reconciliation","volume":"7","author":"Lo","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"2026050406265061300_bib9","first-page":"101","article-title":"Social determinants of disease: HIV and COVID-19 experiences. Curr HIV\/AIDS Rep","author":"Beltran","year":"2022"},{"issue":"10","key":"2026050406265061300_bib10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/jia2.25632","article-title":"COVID-19, HIV and key populations: cross-cutting issues and the need for population-specific responses","volume":"23","author":"Iversen","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2026050406265061300_bib11","first-page":"1017","article-title":"Provision and utilization of COVID-19-related services in Rivers State during the pandemic","volume":"24","author":"Soroye","year":"2024","journal-title":"Niger Health J"},{"key":"2026050406265061300_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijid.2020.06.067","article-title":"Coronavirus outbreak in Nigeria: burden and socio-medical response during the first 100 days","volume":"98","author":"Amzat","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"7","key":"2026050406265061300_bib13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/QAD.0000000000002858","article-title":"Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019-2020","volume":"35","author":"Boyd","year":"2021","journal-title":"AIDS"},{"issue":"3","key":"2026050406265061300_bib14","first-page":"119","article-title":"Socio-demographic profile of people living with HIV\/AIDS (PLWAs) in Port Harcourt, Nigeria","volume":"14","author":"Chijioke","year":"2015","journal-title":"Niger Health J"},{"issue":"1","key":"2026050406265061300_bib15","first-page":"6","article-title":"Quality of life of people living with HIV\/AIDS in Port Harcourt, Nigeria","volume":"14","author":"Okunoye","year":"2015","journal-title":"Niger Health J"},{"issue":"2 Suppl 1","key":"2026050406265061300_bib16","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.7448\/IAS.18.2.19833","article-title":"Providing comprehensive health services for young key populations: needs, barriers and gaps","volume":"18","author":"Delany-Moretlwe","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"2026050406265061300_bib17","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3390\/ijerph17124548","article-title":"The impact of COVID-19 on HIV treatment and research: a call to action","volume":"17","author":"Chenneville","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"2026050406265061300_bib18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300901","article-title":"Prevalence and factors associated with psychological distress among key populations in Nigeria","volume":"19","author":"Ochonye","year":"2024","journal-title":"PLoS One"},{"issue":"7","key":"2026050406265061300_bib19","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25967","article-title":"Adequate funding of comprehensive community-based programs for key populations needed now more than ever to reach and sustain HIV targets","volume":"25","author":"DiCarlo","year":"2022","journal-title":"J Int AIDS Soc"},{"issue":"Suppl 1","key":"2026050406265061300_bib20","first-page":"8","article-title":"Low engagement of key populations in HIV health services in Tanzania: analysis of community, legal and policy factors","volume":"45","author":"Kigombola","year":"2023","journal-title":"Pan Afr Med J"},{"issue":"4","key":"2026050406265061300_bib21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s10508-020-01644-8","article-title":"Disclosure of same-sex sexual practices to family and healthcare providers by men who have sex with men and transgender women in Nigeria","volume":"50","author":"Kokogho","year":"2021","journal-title":"Arch Sex Behav"},{"issue":"7","key":"2026050406265061300_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(15)00078-8","article-title":"The immediate effect of the same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohort","volume":"2","author":"Schwartz","year":"2015","journal-title":"Lancet HIV"},{"issue":"8","key":"2026050406265061300_bib23","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.3390\/ijerph18083956","article-title":"Sex worker health outcomes in high-income countries of varied regulatory environments: a systematic review","volume":"18","author":"McCann","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"2026050406265061300_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1521\/aeap.2021.33.4.290","article-title":"Stigma, social support, and sexual behavior among female sex workers at risk for HIV in Malawi","volume":"33","author":"Ruegsegger","year":"2021","journal-title":"AIDS Educ Prev"},{"key":"2026050406265061300_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.puhe.2020.10.017","article-title":"Towards an inclusive health agenda: people who inject drugs and the COVID-19 response in Africa","volume":"190","author":"Adebisi","year":"2021","journal-title":"Public Health"},{"issue":"3","key":"2026050406265061300_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.18683\/germs.2021.1276","article-title":"COVID-19 in Nigeria: account of epidemiological events, response, management, preventions and lessons learned","volume":"11","author":"Okoroiwu","year":"2021","journal-title":"Germs"},{"issue":"2","key":"2026050406265061300_bib27","first-page":"131","article-title":"Population risk factors for COVID-19 deaths in Nigeria at sub-national level","volume":"35","author":"Hassan","year":"2020","journal-title":"Pan Afr Med J"},{"issue":"4","key":"2026050406265061300_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.sjbs.2016.03.006","article-title":"HIV epidemiology in Nigeria","volume":"25","author":"Awofala","year":"2018","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"2026050406265061300_bib29","first-page":"3","article-title":"A description of HIV prevalence trends in Nigeria from 2001 to 2010: what is the progress, where is the problem?","volume":"18","author":"Bashorun","year":"2014","journal-title":"Pan Afr Med J"},{"issue":"3","key":"2026050406265061300_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/COH.0000000000000788","article-title":"Barriers and facilitators related to COVID-19 vaccine acceptance and uptake among people living with HIV","volume":"18","author":"Krause","year":"2023","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"2026050406265061300_bib31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3390\/vaccines11061081","article-title":"COVID-19 vaccination status as well as factors associated with COVID-19 vaccine acceptance and hesitancy among prisoners and the implications","volume":"11","author":"Shabir","year":"2023","journal-title":"Vaccines"},{"issue":"2","key":"2026050406265061300_bib32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264371","article-title":"Factors influencing COVID-19 vaccine uptake among adults in Nigeria","volume":"17","author":"Adedeji-Adenola","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"2026050406265061300_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012268","article-title":"Addressing sociodemographic disparities in COVID-19 vaccine uptake among youth in Zimbabwe","volume":"8","author":"Larsson","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2026050406265061300_bib34","doi-asserted-by":"crossref","first-page":"102300","DOI":"10.1016\/j.pmedr.2023.102300","article-title":"Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: findings from the C3PNO consortium","volume":"35","author":"Javanbakht","year":"2023","journal-title":"Prev Med Rep"},{"issue":"6","key":"2026050406265061300_bib35","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2123201","article-title":"Vaccine confidence among people who use drugs: a cross-sectional survey","volume":"18","author":"Frew","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"2026050406265061300_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15585\/mmwr.mm7105a3","article-title":"COVID-19 vaccination coverage and vaccine confidence by sexual orientation and gender identity\u2014United States, August 29\u2013October 30, 2021","volume":"71","author":"McNaghten","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"2026050406265061300_bib37","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/j.vaccine.2022.04.097","article-title":"Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries","volume":"40","author":"Leigh","year":"2022","journal-title":"Vaccine"},{"issue":"10","key":"2026050406265061300_bib38","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/medicina59101744","article-title":"Psychological and social aspects of vaccination hesitancy\u2014Implications for travel medicine in the aftermath of the COVID-19 crisis: a narrative review","volume":"59","author":"Milionis","year":"2023","journal-title":"Medicina"},{"issue":"2","key":"2026050406265061300_bib39","doi-asserted-by":"publisher","DOI":"10.1177\/21582440241253326","article-title":"The vaccine-education paradox in a cross-country analysis: education predicts higher and lower vaccination rates","volume":"14","author":"Trepanowski","year":"2024","journal-title":"Sage Open"},{"issue":"7","key":"2026050406265061300_bib40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/vaccines10071038","article-title":"Access to vaccination among disadvantaged, isolated, and difficult-to-reach communities in the WHO European Region: a systematic review","volume":"10","author":"Ekezie","year":"2022","journal-title":"Vaccines"},{"issue":"82","key":"2026050406265061300_bib41","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-022-01678-5","article-title":"Vaccine equity in low- and middle-income countries: a systematic review and meta-analysis","volume":"21","author":"Ali","year":"2022","journal-title":"Int J Equity Health"},{"issue":"1","key":"2026050406265061300_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41256-022-00255-1","article-title":"COVID-19 vaccine hesitancy in Africa: a scoping review","volume":"7","author":"Ackah","year":"2022","journal-title":"Glob Health Res Policy"},{"key":"2026050406265061300_bib43","doi-asserted-by":"crossref","first-page":"05013","DOI":"10.7189\/jogh.12.05013","article-title":"COVID-19 vaccine hesitancy in rural South Africa: deepening understanding to increase uptake and access","volume":"12","author":"Kahn","year":"2022","journal-title":"J Glob Health"},{"issue":"11","key":"2026050406265061300_bib44","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMc2210367","article-title":"The vaccine-hesitant moment. Reply","volume":"387","author":"Larson","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/5\/522\/66838282\/trag005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/5\/522\/66838282\/trag005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:27:00Z","timestamp":1777890420000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/120\/5\/522\/8470985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,2,10]]},"published-print":{"date-parts":[[2026,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trag005","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,2,10]]}}}